Cancer Patients Get Health Benefits for New Treatments
- SEOUL, South Korea (AP) — Starting next month, cancer patients in South Korea can expect significant reductions in treatment costs thanks to an expansion of national health insurance...
- The policy change addresses previous limitations where combination therapies involving newer, expensive drugs alongside existing treatments were excluded from insurance coverage.
- One leukemia patient, identified only as A, faced this dilemma.
Health Insurance Expansion to Lower Cancer Treatment Costs
Table of Contents
SEOUL, South Korea (AP) — Starting next month, cancer patients in South Korea can expect significant reductions in treatment costs thanks to an expansion of national health insurance coverage, according to the Ministry of Health and Welfare.
Combination Therapies Now Covered
The policy change addresses previous limitations where combination therapies involving newer, expensive drugs alongside existing treatments were excluded from insurance coverage. This frequently enough led patients to suspend or forgo treatment due to high out-of-pocket expenses.
One leukemia patient, identified only as A, faced this dilemma. While receiving Dakozen, a treatment for acute myeloid leukemia costing 100,000 won per cycle, its effectiveness was limited. Medical staff recommended a new, 6 million won drug. However, using it in combination with Dakozen would have reclassified Dakozen as a non-covered benefit, raising the patient’s total cost to 8 million won. Faced with this financial burden, A considered halting treatment.
Ministry of health and Welfare Proclamation
On Thursday, the Ministry of Health and Welfare issued an administrative notice detailing the new application standards for nursing benefits, ensuring that existing health benefits are maintained even when combination therapies are used. The amendment takes effect May 1.
The revision clarifies that existing drugs will retain their health insurance benefits when used in conjunction with new therapies approved by the Ministry of Food and Drug Safety for chemotherapy.
Impact on Cancer Treatment
Health officials anticipate the change will greatly improve access to essential cancer treatments. Previously, the exclusion of combination therapies from insurance coverage created a barrier for many patients, particularly those who could benefit from combined immune and targeted anticancer drugs. These combinations have shown promise in improving survival rates and reducing side effects but were often underutilized due to cost concerns.
The medical community reports that the Food and Drug administration has approved 54 anticancer drug combinations, including new drugs, over the past five years. This includes 28 methods of adding new drugs to existing treatments and 26 new drug combinations.
Patient Advocacy Group Responds
According to an official from the Korea Federation of Patient Groups, the revision is a welcome development. “If you use existing benefit treatment with non-paid drugs, the patient has to pay for all the treatment costs,” the official said. “So the patients have to pay for all the treatment costs.”
Health Insurance Expansion to Lower Cancer Treatment Costs: Your Questions Answered
This article provides a thorough overview of the recent health insurance expansion in South Korea, focusing on how it impacts cancer patients and their access to treatment. We’ll address key questions and break down the implications of these changes.
What’s New Regarding Cancer Treatment Costs in South Korea?
Starting next month, cancer patients in South Korea can anticipate reduced treatment costs thanks to an expansion of national health insurance coverage, as announced by the Ministry of Health and Welfare. This policy targets the financial barriers some patients face when undergoing